Cargando…
SAT475 Levothyroxine and Liothyronine Treated Myxedema Coma with Irreversible Cardiopulmonary Failure: A Rare Phenomenon
Disclosure: T. Menon: None. Y. Xie: None. A. Wang: None. Introduction: We describe a case of myxedema coma associated with irreversible cardiogenic shock and the challenges in optimal management. Case Presentation: A previously healthy 23-year-old man with a history of untreated hypothyroidism (TSH...
Autores principales: | Menon, Trisha, Xie, Yan Yan, Wang, Ally |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553740/ http://dx.doi.org/10.1210/jendso/bvad114.1949 |
Ejemplares similares
-
SAT-460 Myxedema Coma Mimicking Cardiogenic Shock Treated with Levothyroxine
por: Chaker, Bayan, et al.
Publicado: (2020) -
SUN-550 Pressor Refractory, Liothyronine Responsive Myxedema Cardiogenic Shock without Myxedema Coma
por: Willis, Cornelia, et al.
Publicado: (2019) -
ODP517 Successful Treatment of Myxedema Coma after SARS-CoV-2 infection with Combination Oral Levothyroxine and Liothyronine
por: Dimayuga, Diana Colleen, et al.
Publicado: (2022) -
SAT-624 Amiodarone-Induced Myxedema Coma
por: Rana, Sanah, et al.
Publicado: (2019) -
SAT-LB83 Amiodarone Induced Myxedema Coma
por: Kim, Keun Young, et al.
Publicado: (2020)